CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
44 hedge funds and large institutions have $104M invested in Crescent Biopharma, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 4 closing their positions.
Holders
44
Holders Change
-7
Holders Change %
-13.73%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
15
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$2.79M |
2 |
2
Wellington Management Group
Boston,
Massachusetts
|
$17.5M |
3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$4.21M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$2.36M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$648K |